We are live on ! Find out more
O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 125.28%
This Fund
S&P 500
This Quarter Est. Return
+34.33%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$4.17B
AUM Growth
+$193M
Cap. Flow
-$193M
Cap. Flow %
-4.62%
Top 10 Hldgs %
41.32%
Holding
120
New
16
Increased
14
Reduced
24
Closed
15

Top Buys

1
DHR icon
Danaher
DHR
+$52.4M
2
CI icon
Cigna
CI
+$48.2M
3
UTHR icon
United Therapeutics
UTHR
+$38.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$29.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$28.9M

Top Sells

1
UNH icon
UnitedHealth
UNH
+$105M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$93.6M
3
THC icon
Tenet Healthcare
THC
+$81.8M
4
BSX icon
Boston Scientific
BSX
+$39.8M
5
CYTK icon
Cytokinetics
CYTK
+$35.6M

Sector Composition

1 Healthcare 99.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
101
AstraZeneca
AZN
$261B
– –
0
– –
CMMB
102
Chemomab Therapeutics
CMMB
$11.1M
– –
-235,248
Closed -$1.09M
CPRX icon
103
Catalyst Pharmaceutical
CPRX
$3.85B
– –
-416,900
Closed -$9.05M
CYTK icon
104
Cytokinetics
CYTK
$11.2B
– –
-1,077,000
Closed -$35.6M
ENGN icon
105
enGene Therapeutics
ENGN
$127M
– –
-677,977
Closed -$2.47M
INMB icon
106
INmune Bio
INMB
$55M
– –
0
– –
ITOS
107
DELISTED
iTeos Therapeutics
ITOS
– –
-700,000
Closed -$6.98M
PFE icon
108
Pfizer
PFE
$141B
– –
0
– –
SRRK icon
109
Scholar Rock
SRRK
$6.48B
– –
0
– –
TGTX icon
110
TG Therapeutics
TGTX
$8.64B
– –
0
– –
THC icon
111
Tenet Healthcare
THC
$16.6B
– –
-465,000
Closed -$81.8M
THRD
112
DELISTED
Third Harmonic Bio
THRD
– –
-5,779,071
Closed -$31.4M
TSBX
113
DELISTED
Turnstone Biologics
TSBX
– –
-3,099,265
Closed -$1.11M
TYRA icon
114
Tyra Biosciences
TYRA
$1.93B
– –
-804,603
Closed -$7.7M
UNH icon
115
UnitedHealth
UNH
$380B
– –
-336,300
Closed -$105M
VRTX icon
116
Vertex Pharmaceuticals
VRTX
$121B
– –
-210,287
Closed -$93.6M
ZLAB icon
117
Zai Lab
ZLAB
$2.31B
– –
-231,000
Closed -$8.08M
LSB
118
DELISTED
LakeShore Biopharma
LSB
– –
-54,799
Closed -$55.9K
1 2 3 4
5

Similar funds

CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $4.61B AUM 25.58% 1-Year Est. Return